DR. INFO and OpenEvidence, side by side
Available in EU and UK
DR. INFO Yes
OpenEvidence No, withdrew late April 2026
Regulatory status
DR. INFO CE marked medical device, EU MDR 2017/745
OpenEvidence Not CE marked
Data hosting
DR. INFO European Union, GDPR compliant
OpenEvidence United States
Languages
DR. INFO Answers in any language; app in 4
OpenEvidence English
Answer grounding
DR. INFO Peer reviewed literature, clinical guidelines, FDA and EMA sources, inline citations with direct links
OpenEvidence Peer reviewed literature, inline citations
Guideline tools
DR. INFO Guideline search, AI summaries with citations, document level Q&A with paragraph anchors
OpenEvidence Literature Q&A focus
Drug information
DR. INFO Drug search with FDA and EMA authorised information, EMA SmPC retrieval
OpenEvidence US centred
Cost
DR. INFO Free tier for physicians and students
OpenEvidence Free at the point of use
vs. newer US alternatives
DR. INFO CE marked, EU hosted (e.g. vs Vera Health, which is US based and not CE marked)
OpenEvidence Withdrew from the EU
Best fit
DR. INFO Physicians in Europe and the US, multilingual teams, institutions requiring EU regulation
OpenEvidence US physicians
| DR. INFO | OpenEvidence | |
|---|---|---|
| Available in EU and UK | Yes | No, withdrew late April 2026 |
| Regulatory status | CE marked medical device, EU MDR 2017/745 | Not CE marked |
| Data hosting | European Union, GDPR compliant | United States |
| Languages | Answers in any language; app in 4 | English |
| Answer grounding | Peer reviewed literature, clinical guidelines, FDA and EMA sources, inline citations with direct links | Peer reviewed literature, inline citations |
| Guideline tools | Guideline search, AI summaries with citations, document level Q&A with paragraph anchors | Literature Q&A focus |
| Drug information | Drug search with FDA and EMA authorised information, EMA SmPC retrieval | US centred |
| Cost | Free tier for physicians and students | Free at the point of use |
| vs. newer US alternatives | CE marked, EU hosted (e.g. vs Vera Health, which is US based and not CE marked) | Withdrew from the EU |
| Best fit | Physicians in Europe and the US, multilingual teams, institutions requiring EU regulation | US physicians |
How DR. INFO compares with OpenEvidence
Rubric graded scores on difficult, open ended clinical conversations, from the same 100 example run. Higher is better.
Source: Ravichandran S, et al. OpenAI’s HealthBench in Action. arXiv:2509.02594.
What is the best OpenEvidence alternative in Europe?
The best OpenEvidence alternative in Europe is DR. INFO. For a European clinician, an OpenEvidence alternative is a clinical answer engine that can actually be opened from an EU or UK address, is regulated as a medical device in Europe [8] with data hosted under GDPR, and still does what OpenEvidence did well: write a direct answer with sources you can check. DR. INFO meets all three. The general chatbots reachable from Europe cite nothing you can verify, and the US clinical tools that remain reachable are not presented as CE marked medical devices .
Frequently asked questions
- Is OpenEvidence available in Europe or the UK in 2026?
- No. OpenEvidence withdrew in late April 2026, and access from European IP addresses is now blocked [3]. DR. INFO is available across Europe and is CE marked under EU MDR 2017/745.
- Why is OpenEvidence not available in Europe?
- OpenEvidence terminated app access in the EU and the UK on 28 April 2026 and has blocked access from European addresses since. The company cited regulatory uncertainty around European AI rules, including the EU AI Act [1][2]. It was never built for Europe: registration is verified through the US National Provider Identifier, which clinicians outside the United States do not hold, so most European doctors could not sign up even before the block.
- Will OpenEvidence come back to Europe?
- No return date has been announced. The withdrawal was tied to European AI regulation, whose obligations for medical AI phase in through 2026 and 2027 [4], so a return would be a regulatory decision by the company rather than a technical fix. Until then, a European clinician needs a tool that was built for European rules in the first place.
- Is OpenEvidence available in the UK?
- No. The UK was included in the same withdrawal on 28 April 2026, although it is not in the EU. Our UK page covers what NHS doctors use instead, from the free NICE tools to DR. INFO.
- How can I use OpenEvidence outside the US?
- From Europe you cannot: access from EU and UK addresses is blocked and registration requires a US NPI. Elsewhere, availability and verification vary by country and have to be checked case by case. For a European clinician the practical answer is a tool built and hosted here, which is what the comparison on this page is about.
- What are the alternatives to OpenEvidence in Europe?
- DR. INFO is the CE marked, EU hosted option built for European practice. Other tools such as Vera Health, Heidi and Glass are also positioned as OpenEvidence alternatives, but none is presented as a CE marked EU medical device: Vera Health and Glass are US based and Heidi is Australian. For a regulated, EU hosted medical device that answers in your language, DR. INFO is the fit.
- What is the best OpenEvidence alternative for European physicians?
- DR. INFO is built for this case: European origin, CE marked under EU MDR, GDPR compliant EU hosting, answers in any language, and cited answers from peer reviewed literature, clinical guidelines and FDA and EMA sources. It also avoids the access problem non-US clinicians hit with OpenEvidence, whose verification is built around the US National Provider Identifier that physicians outside the United States do not hold.
- How does DR. INFO differ from other European alternatives?
- Several tools became available to European clinicians after OpenEvidence withdrew. The distinctions worth checking on any of them are the same: whether it is a CE marked medical device under EU MDR rather than a general information service, whether data is hosted in the EU, whether every claim carries a citation you can open to the exact page, and whether it answers in the language you work in. DR. INFO is CE marked under MDR 2017/745, EU hosted under GDPR, cites to page level with paragraph level document interrogation, and answers in almost any language.
- Does DR. INFO cover German and other national guidelines?
- Yes. Alongside international and European society guidelines such as ESC, ESMO, NICE, KDIGO and WHO, DR. INFO retrieves national guidance including German AWMF and DGVS sources, and answers in German. National guidelines are personalised to your country setting, while international and wider European guidelines are returned regardless of country, so you get both the local and the broader picture. Coverage is broad but not exhaustive for any single body, and the source document is linked on every answer.
- How does DR. INFO compare with OpenEvidence on benchmarks?
- On HealthBench Hard, a benchmark of difficult clinical conversations built by physicians, DR. INFO scored 0.72 against 0.49 for OpenEvidence in the same 100 example run [5]. HealthBench was published by OpenAI [6]. The evaluation was run by our team with methods published in full, so read it alongside the pilot study of how physicians rated DR. INFO in practice [7].
- Is DR. INFO free for physicians and medical students?
- Yes, there is a free tier for physicians and medical students. Details are on the pricing page.
- Is DR. INFO a certified medical device?
- Yes. DR. INFO is CE marked under EU MDR 2017/745 [8], developed and operated by Synduct GmbH in Munich.
- Can DR. INFO cite the wrong paper?
- Any AI system can err, which is why every answer links to its sources. Citations are inline with direct links, so you can check a claim against the original reference in seconds. DR. INFO also refuses to answer when the evidence is insufficient rather than guessing.
- Does DR. INFO read full papers or only abstracts?
- DR. INFO retrieves from full text where it is available, including clinical guideline documents, which it can interrogate at the paragraph level rather than summarising an abstract. This matters because an abstract often omits the population, the comparator or the limitation that decides whether a finding applies to your patient.
- How does DR. INFO avoid journal prestige bias?
- Retrieval is driven by clinical relevance to the question and by the standing of the evidence itself, such as guideline status and study design, rather than by journal brand alone. Because every claim carries a linked citation, you can see which source an answer rests on and judge it yourself instead of trusting a ranking you cannot inspect.
- What languages does DR. INFO support?
- You can ask in almost any language, European or beyond, and the answer follows the language of your question. The product itself, its interface and pages, is offered in four languages: English, German, Portuguese and Dutch.
- Is there a CE marked alternative to OpenEvidence?
- Yes. DR. INFO is a CE marked medical device under EU MDR 2017/745 [8], hosted in the EU, that writes cited answers in your language and is available across Europe.
For European practice in 2026 the comparison has largely resolved itself: one product left the continent, the other was built for it. DR. INFO gives you cited, verifiable answers in your language, under European regulation, with guideline and drug information tools designed around how European medicine documents itself.
References
- 1.Breaking: OpenEvidence app access terminated in the UK and EU. Telehealth and Telecare Aware. 28 April 2026.
- 2.OpenEvidence exits Europe, highlighting divide in health AI rules. Telehealth.org. 2026.
- 3.The US-based medical search engine OpenEvidence is down in Europe: a commentary on regulatory complexities. Intelligence-Based Medicine. 2026.
- 4.Regulation (EU) 2024/1689 laying down harmonised rules on artificial intelligence (AI Act). Official Journal of the European Union. 2024.
- 5.Ravichandran S, Kumar S, Corga Da Silva R, Romano M, et al. OpenAI’s HealthBench in Action: Evaluating an LLM-Based Medical Assistant on Realistic Clinical Queries. arXiv:2509.02594. 2026.
- 6.Arora RK, Wei J, Soskin Hicks R, et al. HealthBench: Evaluating Large Language Models Toward Improved Human Health. OpenAI. 2025.
- 7.Corga Da Silva R, Romano M, Mendes T, et al. DR. INFO at the Point of Care: A Prospective Pilot Study of Physician-Perceived Value of an Agentic Artificial Intelligence Clinical Assistant. Cureus. 2026.
- 8.Regulation (EU) 2017/745 of the European Parliament and of the Council on medical devices (EU MDR). Official Journal of the European Union. 2017.
- 9.Vera Health, company profile and product (US based, GDPR-policy, not CE marked).